These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 10226557)
1. Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines. Aoe K; Kiura K; Ueoka H; Tabata M; Matsumura T; Chikamori M; Matsushita A; Kohara H; Harada M Anticancer Res; 1999; 19(1A):291-9. PubMed ID: 10226557 [TBL] [Abstract][Full Text] [Related]
2. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer. Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517 [TBL] [Abstract][Full Text] [Related]
3. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance. Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170 [TBL] [Abstract][Full Text] [Related]
4. Combined effect of docetaxel and cisplatin for non-small cell lung cancer cell lines in vitro. Wang H Nagoya J Med Sci; 2000 Nov; 63(3-4):129-37. PubMed ID: 11201987 [TBL] [Abstract][Full Text] [Related]
5. Combination treatment with docetaxel (Taxotere) and platinum compounds for non-small cell lung cancer. Mattson K; Saarinen A; Jekunen A Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-5-S14-8. PubMed ID: 9335516 [TBL] [Abstract][Full Text] [Related]
6. Docetaxel in the management of advanced non-small cell lung cancer. Miller VA Semin Oncol; 1998 Jun; 25(3 Suppl 8):15-9. PubMed ID: 9704671 [TBL] [Abstract][Full Text] [Related]
8. Combination effects of cisplatin, vinorelbine and irinotecan in non-small-cell lung cancer cell lines in vitro. Mogi H; Hasegawa Y; Watanabe A; Nomura F; Saka H; Shimokata K Cancer Chemother Pharmacol; 1997; 39(3):199-204. PubMed ID: 8996520 [TBL] [Abstract][Full Text] [Related]
9. Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326). Belani CP; Fossella F Cancer; 2005 Dec; 104(12):2766-74. PubMed ID: 16288485 [TBL] [Abstract][Full Text] [Related]
10. Phase II trials of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancer. Krug LM; Miller VA Semin Oncol; 1999 Oct; 26(5 Suppl 16):24-6; discussion 41-2. PubMed ID: 10585005 [TBL] [Abstract][Full Text] [Related]
11. In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines. Budman DR; Calabro A Breast Cancer Res Treat; 2002 Jul; 74(1):41-6. PubMed ID: 12150451 [TBL] [Abstract][Full Text] [Related]
12. Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC). Vergnenègre A; Daniel C; Léna H; Fournel P; Kleisbauer JP; Le Caer H; Letreut J; Paillotin D; Pérol M; Bouchaert E; Preux PM; Robinet G; Lung Cancer; 2005 Mar; 47(3):395-404. PubMed ID: 15713523 [TBL] [Abstract][Full Text] [Related]
13. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. Fossella F; Pereira JR; von Pawel J; Pluzanska A; Gorbounova V; Kaukel E; Mattson KV; Ramlau R; Szczesna A; Fidias P; Millward M; Belani CP J Clin Oncol; 2003 Aug; 21(16):3016-24. PubMed ID: 12837811 [TBL] [Abstract][Full Text] [Related]
14. Docetaxel (Taxotere) in combination with vinorelbine in non-small cell lung cancer. Miller V Semin Oncol; 1999 Jun; 26(3 Suppl 10):12-4. PubMed ID: 10437745 [TBL] [Abstract][Full Text] [Related]
15. Schedule-dependent synergism and antagonism between pemetrexed and docetaxel in human lung cancer cell lines in vitro. Kano Y; Tanaka M; Akutsu M; Mori K; Yazawa Y; Mano H; Furukawa Y Cancer Chemother Pharmacol; 2009 Nov; 64(6):1129-37. PubMed ID: 19306094 [TBL] [Abstract][Full Text] [Related]
16. In vitro schedule-dependent interaction between irinotecan and vinorelbine in NCI H460 non-small cell lung cancer cell line. Gauvin A; Bressolle F; Martineau P; Astre C; Pinguet F Anticancer Res; 2002; 22(2A):905-12. PubMed ID: 12014670 [TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of antimicrotubule agents in human small-cell lung cancer cell lines. Ikubo S; Takigawa N; Ueoka H; Kiura K; Tabata M; Shibayama T; Chikamori M; Aoe K; Matsushita A; Harada M Anticancer Res; 1999; 19(5B):3985-8. PubMed ID: 10628341 [TBL] [Abstract][Full Text] [Related]
18. Schedule-dependent interactions between vinorelbine and paclitaxel in human carcinoma cell lines in vitro. Kano Y; Akutsu M; Suzuki K; Ando J; Tsunoda S Breast Cancer Res Treat; 1999 Jul; 56(1):79-90. PubMed ID: 10517345 [TBL] [Abstract][Full Text] [Related]
19. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells. Braakhuis BJ; Hill BT; Dietel M; Kelland LR; Aapro MS; Zoli W; Lelieveld P Anticancer Res; 1994; 14(1A):205-8. PubMed ID: 7909419 [TBL] [Abstract][Full Text] [Related]
20. Cisplatin down-regulates topoisomerase I activity in lung cancer cell lines. Aoe K; Kiura K; Ueoka H; Tabata M; Chikamori M; Kohara H; Harada M; Tanimoto M Anticancer Res; 2004; 24(6):3893-7. PubMed ID: 15736428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]